BLOG
Patient Information
Randomized controlled crossover trial of ketamine in obsessive-compulsive disorder: proof-of-concept
October 23, 2025
No Comments
Abstract Serotonin reuptake inhibitors (SRIs), the first-line pharmacological treatment for obsessive-compulsive disorder (OCD), have two limitations: incomplete symptom relief and 2-3 months lag time before
Updates
Our Latest Articles
Elit sit risus lorem proin eget eu molestie nibh odioa non neque turpis proin viverra velarcu venenatis Elit sit risus lorem proin.
October 22, 2025
No Comments
October 22, 2025
No Comments
Randomized controlled crossover trial of ketamine in obsessive-compulsive disorder: proof-of-concept
October 23, 2025
No Comments
